Student Mentorship Series with Thomas Lobl

Students are invited to join Thomas Lobl of the Corporate Relations Board (CRB) for an informal mentorship event. Get tips and suggestions on how to find a meaningful career and ask questions that will assist you with your professional development. All students are welcome to attend.

Prior to his USC role, Dr. Thomas Lobl was the Emerging Technology Strategist at Alfred Mann Foundation. He has a Ph.D. from Johns Hopkins University and post-graduate work at Caltech and Rockefeller University. He has worked in the pharmaceutical industry for 39+ years in both big pharma and biotech start-up companies.

In 2002, he joined the Al Mann family of companies at AlleCure/Mannkind as V.P. and subsequently as Senior V.P. of R&D. In January 2004, he helped to start NeuroSystec and was acting CEO for nearly seven years. NeuroSystec was developing an anti-tinnitus drug. NeuroSystec has been sold to Otonomy (San Diego). Since October 2011, he has worked at the Alfred Mann Foundation as an Emerging Technology Strategist. He has over 74 publications and patents and has been a scientific reviewer or editorial board member in various scientific journals.

He has been a board member and/or officer of a number of scientific organizations and is currently Chair of the American Tinnitus Association Board of Directors. He is/has been on a number of NIH grant review study sections (currently on: Sensory Technologies). Lobl’s scientific and research experience is quite broad and includes medicinal and peptide/protein chemistry, drug discovery and development, clinical development, and drug and tissue-specific delivery systems in cancer, inflammatory, infectious, reproductive, and endocrinology diseases areas. He is currently working in the neurobiology area for diseases/injuries of the brain and peripheral nervous system using medical devices and drug delivery systems. He has helped prepare grants/contracts that have brought in several millions of dollars in research support for AMF in the areas of implanted myoelectric sensors. His personal research interests are in developing skull-mounted pumps, sensors, and microstimulators for treating brain diseases through tissue-specific drug delivery to areas of the brain responsible for various disorders.

Please join the event at 11:45 a.m. as we will being promptly at 12 p.m.

Please RSVP here